“Hepatitis b”的搜索结果，显示 371-380 项，共有 10616 项

1. 肝癌 - 症状与病因- 妙佑医疗国际

   Hepatitis B questions and answers for the public. Centers for Disease Control and Prevention. https://www.cdc.gov/hepatitis/hbv/bfaq.htm. Accessed March 4 ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

4. 血液科- 临床试验- 妙佑医疗国际

   Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able to ...

5. 血液科- 临床试验- 妙佑医疗国际

   Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to compare epcoritamab to standard practice (observation) for the treatment of patients with B-cell lymphomas who are not in ...

7. 前列腺癌 - 医生与科室 - 妙佑医疗国际

   了解前列腺癌的检测、诊断方法、治疗方案和进展，包括机器人前列腺切除术和当前的研究。

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

9. 医生与科室- 妙佑医疗国际

   科室与专家门诊. 妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一，在亚利桑那州、佛罗里达州和明尼苏达州都有院区。医务人员掌握数几十种专业技能，齐心协力， ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...